Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drugs Used in Parasomnia.

Paola Proserpio1, Michele Terzaghi2, Raffaele Manni2

  • 1Department of Neuroscience, Centre of Sleep Medicine, Centre for Epilepsy Surgery, Niguarda Hospital, Piazza Ospedale Maggiore, Milan 3-20162, Italy.

Sleep Medicine Clinics
|May 11, 2020
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Cannabinoid-Based Products in Children and Adolescents with Autism Spectrum Disorder, Fragile X Syndrome and Rett Syndrome: A Systematic Review.

Journal of child and adolescent psychopharmacology·2026
Same author

Aggression in epilepsy and sleep: from historical accounts to brain networks and human behaviour.

Brain : a journal of neurology·2026
Same author

Virtual brain and electroencephalography explain the variance of memory alterations in mild cognitive impairment.

Alzheimer's research & therapy·2026
Same author

Slow-Wave Sleep Fragmentation in Disorders of Arousal and Sleep-Related Hypermotor Epilepsy: A Multicenter Polysomnographic Study.

Neurology·2026
Same author

Clinical markers of disease progression in the prodromal to overt alpha-synucleinopathy continuum.

Brain : a journal of neurology·2026
Same author

Socioeconomic status and perception of well-being and mental health support: a three-year COVID-19 study in children with psychopathology and their parents.

Pediatric research·2026

Patient education and behavioral management are initial treatments for parasomnias like disorders of arousal (DOA). Pharmacologic options, including benzodiazepines and antidepressants, are used when symptoms are severe or persistent, despite a lack of approved DOA drugs.

Area of Science:

  • Neurology
  • Sleep Medicine

Background:

  • Parasomnias, particularly disorders of arousal (DOA), are often initially managed with behavioral interventions.
  • Pharmacologic treatment for DOA is considered when behavioral approaches fail or when episodes pose significant risks.

Purpose of the Study:

  • To review the current treatment strategies for parasomnias, focusing on disorders of arousal and REM sleep behavior disorder.
  • To discuss the role of pharmacologic interventions in managing these sleep disorders.

Main Methods:

  • Literature review of existing studies and clinical guidelines on parasomnia treatment.
  • Analysis of commonly prescribed medications for DOA and REM sleep behavior disorder.

Main Results:

  • Behavioral management is the primary approach for DOA.
Keywords:
Antidepressant drugsBenzodiazepinesClonazepamDisorders of arousalMelatoninREM behavior disorderSleep enuresisSleep-related eating disorder

Related Experiment Videos

  • Benzodiazepines and antidepressants are frequently used for DOA, although no drugs are specifically approved.
  • Clonazepam and melatonin are commonly used for symptomatic treatment of REM sleep behavior disorder.

    • Conclusions:

    • While behavioral strategies are foundational, pharmacologic treatments are essential for managing severe or persistent parasomnias.
    • Further research is needed to develop approved and targeted pharmacologic therapies for DOA.